Topics

AI drug discovery firm spins out of Stanford research

16:10 EST 3 Dec 2019 | MedCity News

Another AI drug discovery firm has sprung up in Silicon Valley with seed investors, including Andreessen Horowitz, kicking in $4.1 million.

Original Article: AI drug discovery firm spins out of Stanford research

NEXT ARTICLE

More From BioPortfolio on "AI drug discovery firm spins out of Stanford research"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...